View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorized
July 25, 2011updated 06 Dec 2021 9:25am

Repligen Initiates RG1068 Drug Study

Repligen has enrolled the first patient in a pilot study to evaluate the ability of RG1068 to improve detection and characterisation of pancreatic cancer. RG1068, a synthetic version of the hormone secretin, is known to stimulate the secretion of pancreatic fluid into the pancreatic duc

By cms admin

Repligen has enrolled the first patient in a pilot study to evaluate the ability of RG1068 to improve detection and characterisation of pancreatic cancer.

RG1068, a synthetic version of the hormone secretin, is known to stimulate the secretion of pancreatic fluid into the pancreatic ducts and to increase blood flow to the tissues of the pancreas.

The study will enrol up to 40 patients with a known or suspected pancreatic mass and will also evaluate which imaging technique is optimal for pancreatic tumour detection, staging and evaluation for surgery.

The addition of RG1068 to standard contrast-enhanced imaging techniques that are currently ineffective in resolving early disease may enable the tumour to become more visible.

Principal investigator of the study Pablo Ros said that RG1068 has the potential to improve the ability to detect and correctly stage pancreatic tumours by CT and MRI scans and may lead to improved patient outcomes.

In previous Phase III studies, RG1068 has shown improvement in detection of pancreatic duct abnormalities in combination with MRI in patients with pancreatitis.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology